-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

HC Wainwright Adjusts ALX Oncology Price Target to $30 From $65, Maintains Buy Rating

HC Wainwright Adjusts ALX Oncology Price Target to $30 From $65, Maintains Buy Rating

MT Newswires · 03/10/2023 02:43